| Literature DB >> 26056931 |
Derek K Smith1, Chun-Li Zhang2.
Abstract
The discovery and in vivo application of cell fate reprogramming concepts have jumpstarted new technologies aimed at the functional regeneration of damaged tissues. As most adult organ systems retain only a limited potential for self-regeneration after trauma, the production of fate-specific cells by in vivo transdifferentiation offers a targeted method for tissue bioengineering. Proof-of-principle studies have demonstrated the induction of neural precursor cells, neurons, cardiomyocytes, and insulin-producing β islet cells. Each of these induced cell types survive, mature, and integrate into the local environment in a functionally meaningful manner. Here, we briefly highlight recent advances in the in vivo reprogramming of cell identity and the current challenges that face the clinical relevance of these methods.Entities:
Mesh:
Year: 2015 PMID: 26056931 PMCID: PMC4607754 DOI: 10.1016/j.ajpath.2015.02.025
Source DB: PubMed Journal: Am J Pathol ISSN: 0002-9440 Impact factor: 4.307